Yingying Xu
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism 2
- Cancer Genomics and Diagnostics 2
- Biomaterials top 10%
-
- RNA regulation and disease 2
-
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
-
- Endoplasmic Reticulum Stress and Disease 3
-
- Liver physiology and pathology 2
-
- Liver Disease Diagnosis and Treatment 2
In The Last Decade
Yingying Xu
18 papers receiving 703 citations
Peers
Comparison fields: 5 of 87
- Cancer Research 184
- Biomaterials 121
- Molecular Biology 373
- Oncology 137
- Immunology 100
Countries citing papers authored by Yingying Xu
This map shows the geographic impact of Yingying Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingying Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingying Xu more than expected).
Fields of papers citing papers by Yingying Xu
This network shows the impact of papers produced by Yingying Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingying Xu. The network helps show where Yingying Xu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yingying Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 7 | |
| 4 | 2024 | 5 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 11 | |
| 8 | 2023 | 90 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 13 | |
| 11 | 2020 | 222 | |
| 12 | 2020 | 156 | |
| 13 | 2020 | 7 | |
| 14 | 2020 | 16 | |
| 15 | 2020 | 1 | |
| 16 | 2018 | 119 | |
| 17 | 2009 | 15 | |
| 18 | 2009 | 10 | |
| 19 | 2006 | 20 |
About Yingying Xu
Yingying Xu is a scholar working on Cancer Research, Geriatrics and Gerontology and Hepatology, having authored 19 papers that have together received 706 indexed citations. Recurring topics across this work include Endoplasmic Reticulum Stress and Disease (3 papers), RNA regulation and disease (2 papers), Cancer, Hypoxia, and Metabolism (2 papers), Liver physiology and pathology (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Cancer Research (184 citations), Biomaterials (121 citations) and Molecular Biology (373 citations). Yingying Xu has collaborated with scholars based in China, Malaysia and Laos. Frequent co-authors include Dalong Ni, Ping Hu, Qingsheng Wu, Qunqun Bao, Jianlin Shi, Junnian Hao, Yuedong Guo, Heliang Yao, Chenyang Wei and Litong Yao. Their work appears in journals such as ACS Nano, Oncogene and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.